Nothing Special   »   [go: up one dir, main page]

NO20024029D0 - Nytt protein og gen som koder for proteinet - Google Patents

Nytt protein og gen som koder for proteinet

Info

Publication number
NO20024029D0
NO20024029D0 NO20024029A NO20024029A NO20024029D0 NO 20024029 D0 NO20024029 D0 NO 20024029D0 NO 20024029 A NO20024029 A NO 20024029A NO 20024029 A NO20024029 A NO 20024029A NO 20024029 D0 NO20024029 D0 NO 20024029D0
Authority
NO
Norway
Prior art keywords
protein
gene encoding
new
new protein
gene
Prior art date
Application number
NO20024029A
Other languages
English (en)
Other versions
NO20024029L (no
Inventor
Makoto Suzuki
Ken Ichi Ishibashi
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Publication of NO20024029D0 publication Critical patent/NO20024029D0/no
Publication of NO20024029L publication Critical patent/NO20024029L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
NO20024029A 2000-02-25 2002-08-23 Nytt protein og gen som koder for proteinet NO20024029L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000048727 2000-02-25
PCT/JP2001/001354 WO2001062915A1 (fr) 2000-02-25 2001-02-23 Nouvelle proteine et gene codant pour elle

Publications (2)

Publication Number Publication Date
NO20024029D0 true NO20024029D0 (no) 2002-08-23
NO20024029L NO20024029L (no) 2002-10-24

Family

ID=18570772

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20024029A NO20024029L (no) 2000-02-25 2002-08-23 Nytt protein og gen som koder for proteinet

Country Status (10)

Country Link
US (1) US20030073117A1 (no)
EP (1) EP1260585A4 (no)
JP (1) JPWO2001062915A1 (no)
KR (1) KR20030004354A (no)
CN (1) CN1432062A (no)
AU (1) AU2001234150A1 (no)
CA (1) CA2400876A1 (no)
HU (1) HUP0300489A3 (no)
NO (1) NO20024029L (no)
WO (1) WO2001062915A1 (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL213159B1 (pl) 2010-04-23 2013-01-31 Inst Biolog Doswiadczalnej Im Marcelego Nenckiego Pan Zmutowane szczepy Escherichia coli, sposób testowania potencjalnych zwiazków antybakteryjnych wykorzystujacy te szczepy oraz zestaw do testowania
CN102199197B (zh) * 2011-04-13 2013-03-27 安徽医科大学 一种具有自组装钾通道功能的多肽及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69819345T2 (de) * 1997-08-20 2004-07-15 The Regents Of The University Of California, Oakland Für den capsaicin rezeptor kodierende nukleinsäuresequenzen und dem capsaicin rezeptor ähnliche polypeptide und ihre verwendung
EP1047711B1 (en) * 1998-01-22 2003-08-20 The Regents of the University of California Nucleic acid sequences encoding capsaicin receptors
GB9826359D0 (en) * 1998-12-01 1999-01-27 Glaxo Group Ltd Novel receptors
CA2359955A1 (en) * 1999-11-12 2001-05-17 Abbott Laboratories Human vanilloid receptor gene
US20020072101A1 (en) * 2000-01-21 2002-06-13 Gaughan Glen T. Novel human nucleic acid molecules and polypeptides encoding cation channels
US6455278B1 (en) * 2000-02-08 2002-09-24 Ortho-Mcneil Pharmaceutical, Inc. DNA encoding human vanilloid receptor VR3
EP1170365A1 (en) * 2000-07-04 2002-01-09 Smithkline Beecham Plc Member of the ion channel family of polypeptides; vanilrep4

Also Published As

Publication number Publication date
NO20024029L (no) 2002-10-24
WO2001062915A1 (fr) 2001-08-30
KR20030004354A (ko) 2003-01-14
EP1260585A1 (en) 2002-11-27
US20030073117A1 (en) 2003-04-17
JPWO2001062915A1 (ja) 2004-01-08
EP1260585A4 (en) 2005-02-02
AU2001234150A1 (en) 2001-09-03
HUP0300489A3 (en) 2006-06-28
CA2400876A1 (en) 2001-08-30
CN1432062A (zh) 2003-07-23
HUP0300489A2 (hu) 2003-08-28

Similar Documents

Publication Publication Date Title
NO20034962D0 (no) Beta-amyloid peptid-bindende proteiner og polynukleotider som koder for samme
DK0965578T3 (da) Hidtil ukendt triglycerik og præparat, som omfatter dette
LU91584I2 (fr) Ustekinumab (Stelara)
DK1268431T3 (da) 3-Cyanoquinoliner, 3-cyano-1,6-naphthyridiner og 3-cyano-1,7-naphthyridiner som proteinkinaseinhibitorer
NO20005173D0 (no) Gen som koder for heliomicin og anvendelse derav
EP1365022A4 (en) ADIPONECTIN-ASSOCIATED PROTEIN
NO20032963L (no) Peptidforbindelser
NO20024029D0 (no) Nytt protein og gen som koder for proteinet
DK1317478T3 (da) Skelnen mellem GnRH-I og GnRH-II
GB0025677D0 (en) New protein
NO20030809D0 (no) Nytt proteasegen
EP1375656A4 (en) NEW PROTEINS AND DNA ENCODING IT
AU2002353208A8 (en) Metalloprotease proteins
SE0104413D0 (sv) New protein
GB0106318D0 (en) Protein
GB0130721D0 (en) Protein
SE0102061D0 (sv) New proteins and the corresponding DNA sequences
GB0108588D0 (en) New protein
SE0102633D0 (sv) New polypeptides
SE0100968D0 (sv) General media platform
ATA8102001A (de) Sitzmöbel
GB0130558D0 (en) Protein
GB0130740D0 (en) Protein
GB0124637D0 (en) Protein
GB0125071D0 (en) Protein

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application